Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An announcement from BioNxt Solutions ( (TSE:BNXT) ) is now available.
BioNxt Solutions Inc. has successfully closed the final tranche of its non-brokered private placement of unsecured convertible debentures, raising a total of $3,000,000. The funds raised will be allocated towards product development, intellectual property filings, and general working capital, potentially enhancing the company’s market positioning and operational capabilities.
More about BioNxt Solutions
BioNxt Solutions Inc. operates in the biotechnology industry and focuses on product development, intellectual property filings, and general working capital. The company is listed on multiple exchanges, including the Canadian Securities Exchange, and is involved in financing activities to support its operations.
YTD Price Performance: -10.36%
Average Trading Volume: 10,336
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $32.39M
Find detailed analytics on BNXT stock on TipRanks’ Stock Analysis page.
